Wolverine Trading, LLC Caladrius Biosciences, Inc. Call Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.74 $3,444 - $6,216	8,400 Added 22.22%	46,200 $25,000
Q1 2022 May 16, 2022	BUY	$0.63 - $1.03 $23,814 - $38,934	37,800 New	37,800 $29,000
Q4 2021 Feb 14, 2022	SELL	$0.83 - $1.22 $18,343 - $26,962	-22,100 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.15 - $1.57 $25,414 - $34,697	22,100 New	22,100 $26,000
Q3 2020 Nov 13, 2020	SELL	$1.6 - $3.0 $20,480 - $38,400	-12,800 Closed	0 $0

Q2 2020 Aug 13, 2020	BUY	$1.66 - $2.38 $21,248 - $30,464	12,800 New	12,800 $23,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.